Outcome was not improved for patients receiving capecitabine ( HR 0.92 ; P = 0.463 for DFS and HR 93 ; P = 0.618 for OS ) as well as for patients receiving 36 weeks of chemotherapy ( HR 0.97 ; P = 0.818 for DFS and HR 0.97 ; P = 0.825 for OS ) .